HH-GV-678

Known as: HH-GV678, HHGV678, flumatinib 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2014
0120082014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Activating mutations in KIT have been associated with gastrointestinal stromal tumors (GISTs). The tyrosine kinase inhibitor… (More)
Is this relevant?
2013
2013
The objective of this study was to investigate the effect of the new generation of tyrosine kinase inhibitor flumatinib mesylate… (More)
Is this relevant?
2012
2012
Flumatinib is an antineoplastic tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia (CML). Its major… (More)
  • figure 2
  • table 1
  • figure 4
Is this relevant?
2010
2010
4-(4-Methyl-piperazin-1-ylmethyl)-N-[6-methyl-5-(4-pyridin-3-yl-pyrimidin-2-ylamino)-pyridin-3-yl]-3-trifluoromethyl-benzamide… (More)
  • table 1
  • table 2
Is this relevant?
2008
2008
This study was aimed to compare HHGV678 with imatinib (IM) in growth inhibition of Bcr-Abl wild type and IM-resistant cell lines… (More)
Is this relevant?